Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

ZNF34 ZNF668 ZNF211 ZNF497 ZBED4 ZBTB43 ZNF790 MECOM CHD2 ZNF625 RREB1 BARX1 ZNF784 ZNF439 ZNF709 MXD1 IKZF5 ZNF563

8.53e-0814595818GO:0000977
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.14e-0716584GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

2.40e-0719584GO:0032394
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

ZNF34 ZNF668 ZNF211 ZBED4 ZBTB43 ZNF790 MECOM ZNF625 RREB1 BARX1 ZNF784 ZNF439 ZNF709 MXD1 IKZF5 ZNF563

1.67e-0614125816GO:0000981
GeneOntologyMolecularFunctionimmune receptor activity

KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

8.24e-06165586GO:0140375
GeneOntologyMolecularFunctionMHC class I receptor activity

KIR2DS5 KIR3DL1 KIR3DS1

1.84e-0518583GO:0032393
GeneOntologyMolecularFunctionMHC protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

2.42e-0558584GO:0042287
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM CHD2 RREB1 ZNF784 ZNF709 MXD1 IKZF5

4.54e-0512445813GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM CHD2 RREB1 ZNF784 ZNF709 MXD1 IKZF5

5.66e-0512715813GO:0000987
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

ERBB3 CRIM1 AVPR2 PKD1 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.31e-0413535812GO:0004888
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

KIR2DS5 KIR3DL1

5.37e-0412582GO:0032396
GeneOntologyBiologicalProcessimmune response-regulating signaling pathway

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.18e-056156110GO:0002764
GeneOntologyBiologicalProcessregulation of immune response

KIR2DL5B KIR2DS2 KIR2DL5A EVPL KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 EIF4E2

6.72e-0510856112GO:0050776
MousePhenoabnormal myocardium layer morphology

ERBB3 LZTR1 PKD1 MECOM CHD2 MYO18B RREB1

5.11e-05414347MP:0005329
MousePhenoabnormal heart layer morphology

ERBB3 LZTR1 PKD1 MECOM CHD2 MYO18B RREB1

5.77e-05422347MP:0010545
MousePhenoabnormal mandibular nerve morphology

ERBB3 CRIM1

1.20e-047342MP:0009800
MousePhenoabnormal blood circulation

FLNA ERBB3 LZTR1 CRIM1 PKD1 MECOM WDR27 CHD2 MYO18B

1.37e-04845349MP:0002128
MousePhenoabnormal cardiac muscle tissue morphology

ERBB3 LZTR1 PKD1 MECOM CHD2 MYO18B RREB1

1.45e-04489347MP:0010630
MousePhenoabnormal aorta morphology

FLNA CRIM1 PKD1 MECOM WDR27

1.96e-04225345MP:0000272
DomainZnf_C2H2-like

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 RBM6 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

4.44e-097966216IPR015880
DomainZnF_C2H2

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 RBM6 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

5.49e-098086216SM00355
Domainig

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.23e-08190629PF00047
DomainImmunoglobulin

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.23e-08190629IPR013151
DomainZINC_FINGER_C2H2_2

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

2.45e-087756215PS50157
DomainZINC_FINGER_C2H2_1

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

2.54e-087776215PS00028
Domain-

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF709 IKZF5 ZNF563

3.56e-0867962143.30.160.60
DomainZnf_C2H2

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

4.05e-088056215IPR007087
DomainZnf_C2H2/integrase_DNA-bd

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF709 IKZF5 ZNF563

4.68e-086946214IPR013087
Domainzf-C2H2

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF709 ZNF563

3.51e-076936213PF00096
Domainzf-C2H2_6

ZNF668 ZNF211 ZNF497 ZNF790 MECOM ZNF625 RREB1 ZNF439 ZNF709

8.88e-07314629PF13912
DomainIG

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.72e-06421629SM00409
DomainIg_sub

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.72e-06421629IPR003599
DomainEnvoplakin

EVPLL EVPL

1.08e-052622IPR030460
DomainNPIP

NPIPA5 NPIPA1 NPIPA7

1.24e-0514623IPR009443
DomainIg-like_dom

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.96e-05503629IPR007110
DomainIg-like_fold

FLNA KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.01e-047066210IPR013783
DomainIG_LIKE

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

2.10e-04491628PS50835
Domain-

FLNA KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

3.20e-046636292.60.40.10
DomainKRAB

ZNF34 ZNF211 ZNF790 ZNF439 ZNF709 ZNF563

1.18e-03358626PS50805
DomainKRAB

ZNF34 ZNF211 ZNF790 ZNF439 ZNF709 ZNF563

1.18e-03358626PF01352
DomainKRAB

ZNF34 ZNF211 ZNF790 ZNF439 ZNF709 ZNF563

1.38e-03369626SM00349
DomainKRAB

ZNF34 ZNF211 ZNF790 ZNF439 ZNF709 ZNF563

1.40e-03370626IPR001909
DomainSpectrin/alpha-actinin

EVPLL EVPL

5.04e-0332622IPR018159
DomainSPEC

EVPLL EVPL

5.04e-0332622SM00150
DomainMyosin_head_motor_dom

MYO3B MYO18B

7.06e-0338622IPR001609
DomainMYOSIN_MOTOR

MYO3B MYO18B

7.06e-0338622PS51456
DomainMyosin_head

MYO3B MYO18B

7.06e-0338622PF00063
DomainMYSc

MYO3B MYO18B

7.06e-0338622SM00242
DomainBTB

KLHL29 LZTR1 ZBTB43

9.44e-03131623PF00651
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS2 KIR2DL5A KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1

3.55e-0946416M27151
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

5.49e-0988417M16004
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

1.20e-07137417M5669
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL5A KIR2DL1 KIR2DL3 KIR3DL1

5.77e-0641414M13519
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.75e-0554414MM14871
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1

2.13e-04190415M8240
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

6.19e-04135414MM14781
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.05e-2613641019120281
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.09e-2417641019218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.09e-2417641020878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.09e-2417641020650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.09e-2417641019450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.09e-2417641019761533
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.37e-241164919664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.94e-231264920371502
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.94e-231264920137308
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.94e-231264919936734
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.87e-2320641020193031
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.55e-231364918687225
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.35e-2222641020492596
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.67e-221464919875891
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.67e-221464919421224
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.67e-221464915896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564920082646
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564920643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564919326408
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564919926642
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564919850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564920207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564919493232
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.67e-221564920356536
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664919897003
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664919279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664917868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664918643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664919309280
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664919000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664920670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664919527230
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664920331834
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664920652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664918668235
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

1.52e-211664916403292
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.52e-211664920210919
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.23e-211764920173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.23e-211764920483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.23e-211764919968064
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.23e-211764919169284
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.45e-211864919046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.45e-211864919846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.45e-211864919630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.45e-211864920519398
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

6.45e-211864920200544
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.45e-211864920580654
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.22e-201964918778326
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.22e-201964918571006
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.22e-201964920600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.22e-201964918848853
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.37e-201164818830515
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.22e-202064920426625
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.77e-2035641019683555
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.88e-202164919861144
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.11e-201264819181658
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.11e-201264817490516
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.07e-191364819934297
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

2.48e-191464819489269
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.48e-191464818945962
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

5.32e-191564817498266
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.31e-182964920082482
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.00e-181764819032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1

2.00e-181764820173784
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.60e-181864820210918
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL5A KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1

8.52e-16864617200871
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5

8.52e-16864618681957
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1

2.55e-1596467749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.55e-1596468662091
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

2.55e-15964618340360
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1

6.37e-151064612559621
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL5B KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.37e-151064621206914
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

1.80e-14564510424431
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DL5A KIR2DS1 KIR3DL1 KIR3DS1

1.08e-13664520528243
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DS4 KIR2DS5 KIR3DL1

3.77e-13764514607943
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

3.77e-13764511169255
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1

3.77e-1376459430220
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1

1.00e-1286459430221
Pubmed

Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.

KIR2DL5B KIR2DL5A KIR2DS5 KIR3DS1

1.04e-11464422652695
Pubmed

Activating KIR genes are associated with ankylosing spondylitis in Asian populations.

KIR2DL5A KIR2DS5 KIR3DL1 KIR3DS1

1.04e-11464418638658
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.04e-11464418632158
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.04e-11464423354323
Pubmed

Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients.

KIR2DL5A KIR2DS1 KIR2DS5 KIR3DS1

1.04e-11464425253288
Pubmed

In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.

KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5

5.20e-11564419410616
Pubmed

KIR gene in ethnic and Mestizo populations from Mexico.

KIR2DL5A KIR2DS1 KIR2DS5 KIR3DS1

5.20e-11564416698429
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1

5.20e-11564416112031
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1

5.20e-1156447716543
Pubmed

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

5.20e-11564427893413
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1

5.20e-11564418755860
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL3 KIR2DS1 KIR3DS1

1.56e-10664417882223
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.63e-10764415748957
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.63e-10764426928464
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.63e-10764412618911
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

7.26e-10864415730517
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR2DS2 KIR2DL5A KIR2DS1 KIR3DS1

1.30e-09964418074414
Pubmed

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.

KIR2DS2 KIR2DL1 KIR2DS1

5.94e-09364329549293
Pubmed

KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

KIR2DS4 KIR3DL1 KIR3DS1

5.94e-09364319859704
Pubmed

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

KIR2DS2 KIR2DS4 KIR3DS1

5.94e-09364323325834
Pubmed

Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

KIR2DL5B KIR2DL5A KIR2DS1

5.94e-09364318461314
Pubmed

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.

KIR2DL1 KIR2DL3 KIR3DL1

5.94e-09364330698860
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR3DL1 KIR3DS1

4.97e-0813604int:KIR2DL2
InteractionKIR3DP1 interactions

KIR2DS2 KIR2DL1 KIR2DS5

1.00e-074603int:KIR3DP1
InteractionKIR2DS2 interactions

KIR2DS2 KIR2DS1 KIR2DS5 KIR3DL1

4.36e-0637604int:KIR2DS2
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR3DL1

7.02e-0613603int:KIR3DL1
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DS5

2.76e-0520603int:KIR2DS3
InteractionKIR2DS1 interactions

KIR2DS2 KIR2DS1

5.21e-054602int:KIR2DS1
InteractionZNF790 interactions

TINF2 ZNF790

8.67e-055602int:ZNF790
Cytoband19q13.4

ZNF211 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.11e-157964919q13.4
CytobandEnsembl 112 genes in cytogenetic band chr19q13

ZNF211 ZNF497 ZNF790 KIR2DL1 KIR2DL3 KIR2DS4 ZNF784 KIR3DL1

2.46e-041192648chr19q13
Cytoband19p13.2

ZNF625 ZNF439 ZNF709 ZNF563

3.03e-0422964419p13.2
CytobandEnsembl 112 genes in cytogenetic band chr16p13

NPIPA5 PKD1 NPIPA1 ZNF598 NPIPA7

3.27e-04426645chr16p13
Cytoband16p13.11

NPIPA5 NPIPA1

4.75e-042364216p13.11
Cytoband14q12

ADCY4 TINF2

2.71e-035564214q12
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL5B KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

8.17e-22185310620
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF34 ZNF668 ZNF211 ZNF497 ZBTB43 ZNF790 MECOM ZNF625 RREB1 ZNF784 ZNF439 ZNF598 ZNF709 IKZF5 ZNF563

1.28e-09718531528
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

1.78e-05394538471
GeneFamilyEF-hand domain containing|Plakins

EVPLL EVPL

2.33e-048532939
GeneFamilyBasic leucine zipper proteins|BTB domain containing

KLHL29 LZTR1 ZBTB43

7.12e-03134533861
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1

2.61e-1149637M40909
CoexpressionGSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN

KIR2DS2 KIR2DL5A KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 MXD1

1.81e-08190638M4662
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

CRIM1 KIR2DS2 KIR2DL5A KIR2DL1 KIR2DL3 KIR2DS5 KIR3DS1

5.05e-07199637M9885
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL

KIR2DL1 KIR2DL3 KIR3DL1

1.05e-0518633M45763
ToppCellmild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FLNA KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

5.95e-06198585dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCellmild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FLNA KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

5.95e-061985851d20fc9948965de52a98f758035edfdd12cafc5f
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZNF598

4.85e-05154584ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells)

FSCN3 TRPV3 KIR2DL1 KIR2DL3

4.85e-05154584a39877cdf7b441b5c953f744ed30f1d5acf4ea19
ToppCell5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ERBB3 EVPLL OTOP2 NPIPA1

4.97e-051555845fabe24a784f0be46040ffc886eabd8d5ce78121
ToppCellSevere-Lymphoid-NK-|Severe / Condition, Lineage, Cell class and cell subclass

ZNF34 KIR2DL1 KIR2DL3 ZNF625

5.63e-05160584d276c6cb8317d5fb19e7b4fe5238abaf0272d4c6
ToppCellSevere-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass

ZNF34 AVPR2 IKZF5 ANKRD16

6.05e-051635848f0d8c124f1569a5a6bc1db7581989f24d63cca3
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ERBB3 ASPG NPIPA5 RREB1

6.19e-05164584d6f71d804bb65301c02ea4e6673e20688b5fcd5b
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells)

ZNF34 MCM3 KIR3DL1 KHDC1

6.96e-0516958402fa66a91b8bd2bf971aec4f5ec58318b5bfdf14
ToppCell10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

FLNA MYO3B KIR2DL1 KIR3DL1

7.28e-051715841ee505b91f15191d294a5d491ecdf154c08b8622
ToppCell3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNF497 GAL3ST1 OTOP2 MXD1

7.28e-05171584317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

FLNA KIR2DL1 KIR2DL3 KIR3DL1

7.45e-05172584701de463f85aaad3a4b36a0d5fbc416406620089
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FAM156A KIR2DL1 KIR2DL3 KIR3DL1

7.62e-0517358479d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ERBB3 CRIM1 MECOM CHD2

8.14e-051765843bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCellwk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ADCY4 CRIM1 MECOM NPIPA7

8.69e-051795848c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.01e-04186584e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.01e-041865841590fe72badffc79f1d390deb3207116ac2281bb
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.09e-041905841f890be1ac8613a098b271945f25a58c3c2530ab
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.09e-04190584d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADCY4 KIR2DL3 KIR3DL1 ZNF598

1.14e-04192584930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCellPCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KIR2DL1 KIR2DL3 MYO18B KIR3DL1

1.14e-041925846eadf0f37beae22838e930ad897a9b89e5e12cdb
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADCY4 KIR2DL3 KIR3DL1 ZNF598

1.14e-04192584c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TRPV3 KIR2DL1 KIR2DL3 KIR3DL1

1.16e-0419358491a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCelldroplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGAP32 GAL3ST1 OTOP2 EVPL

1.16e-0419358455eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818
ToppCelllymphoid-NK_cell|World / Lineage, cell class and subclass

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.19e-041945844bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.19e-04194584ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.19e-041945843a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCellmetastatic_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.21e-04195584184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.21e-04195584e756733cf48768bf40058d6cf9039e52f7563133
ToppCellwk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ERBB3 ASPG MECOM EVPL

1.21e-041955840e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCellT/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.21e-041955846124e87cb9061bf8918377fb4a79084079ddfc16
ToppCell10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-04196584e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-0419658478b28b263deaa43590b38597186222c6447ad25f
ToppCell10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-04196584f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-041965843e78e307c9c991c1aadc85c61d401431cf75eaec
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-04196584f0566f2ef96584ed6d9247b149218376fb509915
ToppCellmLN-T_cell-gd_T|T_cell / Region, Cell class and subclass

CRIM1 FSCN3 TRPV3 KIR2DL1

1.23e-041965848f476408cd5a4ea9d25c763c66565343d7989b38
ToppCell10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.23e-04196584a3b077e82b1550eb328c84b567b60179001f9a77
ToppCellsevere-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.26e-041975848bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCelltumor_Lung-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.26e-04197584e9fac2c923179b2b8b0500076421c6fb09960b56
ToppCellmLN-T_cell-gd_T|mLN / Region, Cell class and subclass

CRIM1 FSCN3 TRPV3 KIR2DL1

1.26e-041975848ef03bdbd34a874671aebfdbb7111106aa37b2a9
ToppCellmLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype

CRIM1 FSCN3 TRPV3 KIR2DL1

1.26e-041975845c781ded147db2f3804ee1f21ef0898c4f354890
ToppCellT/NK_cells-CD56dim_NK_cell|T/NK_cells / Lineage and Cell class

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.26e-04197584722d00a218755cc8cb7b5ab2a7fca40269247c3a
ToppCellsevere-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.28e-041985846ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCellControl-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class

FAM156A FLNA ADCY4 KIR3DL1

1.28e-0419858476d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.28e-041985841a189b2b213099505c5d871fb8aedd55a97d44e0
ToppCellcontrol-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.28e-041985841c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.31e-041995840902b08e3386e64d7347c186d9ce5b67f2deaabb
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.31e-041995844e7be837fd23934a338864380fa24b00db007358
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.31e-0419958400ef3cc5c02639bfb839075ecf5f20026ff81f84
ToppCellcontrol-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.31e-041995848aca7775b3d34fd26c7b23ddb23f5f2df72684b0
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA KIR2DL1 KIR2DL3 KIR3DL1

1.33e-042005840f8e2fed93cc103b20a825d8d3e83787c5c015cc
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MYO3B WDR27 MYO18B

2.06e-0488583b4620e79ea80681305434707e87cb02a7c6a5e4f
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MYO3B WDR27 MYO18B

2.06e-04885837992f8e621edf464bffcb70a6cc5f3b60c1d96f8
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MYO3B WDR27 MYO18B

2.06e-0488583b7b55f51af8ffa82813a4747580985a430da9ed1
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MYO3B EVPL RNF180

2.51e-04945839664f74bc0168c92fb8a68cad628323c476f6103
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MYO3B EVPL RNF180

2.51e-0494583c73e99890431750b74f984de5c82e33533ab708b
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MYO3B EVPL RNF180

2.51e-04945831bda61101f45f5c4a68453087b880fdc6d9acfca
ToppCellfrontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADCY4 MECOM BARX1

3.38e-041045835d9cd14e53a2f1060e528abf6c0694be9d72c356
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9

KIR2DL3 KIR2DS4 KIR3DL1

4.53e-0411558355a56828f86c004cd11d1a426a03e86246e949a3
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor

ERBB3 MECOM EVPL

6.77e-041325838d30b71776f5f6da55dc78e0c5cb27be460004e3
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

9.06e-041465830e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

9.24e-041475833ed5b020ce1f1277917d79ef1f7da53fa474e8db
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ERBB3 OTOP2 MECOM

9.43e-041485839fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9

EVPLL MECOM TOP2B

9.61e-0414958389705865e94360c1288ee98c5a6b381f3c6242b3
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells)

PKD1 MCM3 EIF4E2

9.61e-0414958341f28138bde45d0b814e116837e5a32b5e80d54a
ToppCell368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

9.80e-0415058317b3ac5ddc47b9cba0a27b268d63a6e491b2b111
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

9.99e-04151583512f7f37ddc8dfa1906f7fff92b571929236c9ea
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FSCN3 MYO3B TRPV3

1.06e-03154583ea5d0da5dd8ccfc19969aec35f044db77d589f54
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1

1.08e-031555831c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

1.10e-03156583a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY4 MCM3 TRPV3

1.12e-031575832c946c6ab284fac3c25db688ed0aabe5a3f9ffa5
ToppCell367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LZTR1 KIR2DL1 KIR2DL3

1.12e-03157583f511871e1a004c6e9af08ee325ab1bfc41807487
ToppCell368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

1.12e-03157583ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLNA RREB1 NPIPA7

1.18e-031605836ed37d1fd0304932319d6b942502404115ff36a7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL29 ZNF784 MXD1

1.20e-031615837d1bc73f4c82465b3f489d6737048b0cd54f22cf
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL29 ZNF784 MXD1

1.20e-03161583410eef62c83c704cbfc5a1b643c4db11bbdcd81f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL29 ZNF784 MXD1

1.20e-0316158371022485da6754a2b57b4c3e758e3de4c95cc292
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1

1.20e-03161583f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL29 ZNF784 MXD1

1.20e-0316158359ae8a7c9a04ecaa335b8064852a5a91a21780bd
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1

1.24e-03163583466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCellRSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster

MYO3B WDR27 ZNF598

1.27e-03164583ab312b8c2f828ea7331f2a340c4df81587a23b5c
ToppCellRSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster

MYO3B WDR27 ZNF598

1.27e-031645831b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRIM1 MYO3B MXD1

1.29e-03165583eeb58d4db64ad37dc6b441eab22b05c24862e1a9
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY4 CRIM1 MECOM

1.31e-031665837a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCelldroplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLHL29 ARHGAP32 ASPG

1.31e-031665839adceb746e67e955fd8b3e0984f4eed44b64a270
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY4 CRIM1 MECOM

1.31e-03166583bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1

1.36e-03168583240ea32b64d86f9216785010d6b237d9adf052c9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1

1.36e-03168583b4bb03efb601a61465260f93896c56861c588bef
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR3DL1

1.38e-03169583a3234904d7ff8f451ca894e93badd61d75e3cd2a
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1

1.38e-03169583e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCellASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 MYO18B KIR3DL1

1.40e-0317058384705434234bf2fbb5256bd5a1f6ab54c01c5a51
ToppCell356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

TRPV3 MYO18B ZNF563

1.40e-03170583513d9036aa41d4d902da8baa66a66206abb6f3b0
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ASPG EVPL MXD1

1.40e-0317058313a225e32132e9717debb0d64d7c28ada974c3e6
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNA KIR2DL1 KIR3DL1

1.43e-03171583187b396059f8802265f54bad2b4882cebb809419
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

MCM3 KIR2DL3 KIR3DL1

1.43e-031715834ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCellnormal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass

FLNA KIR2DL1 KIR2DL3

1.43e-031715836be81c20f4e962b414afcedfe478dd59c510d1e1
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KLHL29 ZNF790 EVPL

1.43e-03171583dd37e1693a5cfc42e40992d504f92048a8038b52
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL3 KIR3DL1

1.43e-03171583adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCellASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 MYO18B KIR3DL1

1.45e-03172583c9e738c3540ee09b08805b1cdb66b4a0d9d40d33
ComputationalNeighborhood of IL2RB

KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1

8.49e-0646314GNF2_IL2RB
DrugD-Au

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

5.88e-0877616CID000277822
DrugAa1

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

9.24e-0883616CID009549188
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

9.85e-063542OBA_2042107
Diseaseacquired immunodeficiency syndrome (is_implicated_in)

KIR2DL1 KIR3DS1

1.17e-049542DOID:635 (is_implicated_in)
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3

3.40e-0415542EFO_0801746
DiseaseMyeloid Leukemia

MECOM TOP2B

4.94e-0418542C0023470
DiseaseLeukemia, Monocytic, Chronic

MECOM TOP2B

4.94e-0418542C0023466
Diseasecomplement factor D measurement

MYO3B KIR2DL1 KIR2DL3

6.69e-0493543EFO_0020283
Diseasemalaria (is_implicated_in)

KIR3DL1 KIR3DS1

8.84e-0424542DOID:12365 (is_implicated_in)
Diseasehepatitis C (is_implicated_in)

KIR3DL1 KIR3DS1

1.21e-0328542DOID:1883 (is_implicated_in)
Diseasetuberculosis (is_implicated_in)

KIR3DL1 KIR3DS1

1.21e-0328542DOID:399 (is_implicated_in)
DiseaseThrombocytopenia

ASPG IKZF5

1.29e-0329542C0040034
DiseaseEpileptic encephalopathy

FLNA CHD2

1.38e-0330542C0543888
Diseasechronic obstructive pulmonary disease

ERBB3 CRIM1 MECOM MCM3 RREB1 TOP2B

1.57e-03688546EFO_0000341
Diseasepeptic ulcer disease

MECOM BARX1

1.67e-0333542MONDO_0004247

Protein segments in the cluster

PeptideGeneStartEntry
EYEYMNRRRRHSPPH

ERBB3

1196

P21860
YKRPLHEAASMGHRD

ANKRD16

71

Q6P6B7
DAGMEHRDPYLRELG

ADCY4

426

Q8NFM4
DMYHLSREGEAHERR

KIR2DS2

156

P43631
RMAAVEHRHSSGLPY

NPIPA1

216

Q9UND3
DMYHLSREGRAHEPR

KIR2DL5A

151

Q8N109
HETMAPDIHEERQYR

MECOM

196

Q03112
DMYHLSREGEAHERR

KIR2DS4

156

P43632
RRHRDHMAPYAVGRE

FAM156A

96

Q8NDB6
RREREAEHGYASMLP

MXD1

21

Q05195
PQRRYGHTMVAFDRH

LZTR1

281

Q8N653
DMYHLSREGEAHERR

KIR2DL3

156

P43628
TLPMFHDEEHARARG

ASPG

41

Q86U10
EGCADHRPHRYRSFM

BARX1

16

Q9HBU1
DMYHLSREGRAHEPR

KIR2DL5B

151

Q8NHK3
DMYHLSREGGAHERR

KIR3DL1

251

P43629
DLMADPAGVRREYEH

EVPLL

211

A8MZ36
DLMADPAGVRREYEH

EVPL

256

Q92817
RFYRRHPEAEMDRAH

ARHGAP32

1826

A7KAX9
PFASAYERHLEAHMR

IKZF5

116

Q9H5V7
DMYHLSREGEAHERR

KIR2DS5

156

Q14953
GSIIYRFDRRAMDHH

OTOP2

346

Q7RTS6
EISDHVLRMHRYRAP

MCM3

496

P25205
HMRFHYDEVRGLVPT

GAL3ST1

141

Q99999
GDRRHMDAHRSGSYR

CHD2

1676

O14647
RYAPSEAGLHEMDIR

FLNA

1831

P21333
RRHRAVMADGHPLES

FSCN3

321

Q9NQT6
VHLPRDMGHLQVDYR

CRIM1

911

Q9NZV1
SYHHARGLEMLERVR

KHDC1

166

Q4VXA5
DPERRDHRMNHFRVY

FAM183BP

101

Q6ZVS7
RFYSHMVRPGDLTGH

EIF4E2

96

O60573
DMYHLSREGEAHERR

KIR2DL1

156

P43626
MLYGVDSRSGHRHLD

PKD1

3141

P98161
TRRQFPHGAHRMDYL

RNF180

536

Q86T96
DMYHLSREGEAHERR

KIR2DS1

156

Q14954
RMAAVEHRHSSGLPY

NPIPA7

216

E9PJI5
RMAAVEHRHSSGLPY

NPIPA8

216

P0DM63
RGREAPHMNYRDRDA

RBM6

146

P78332
YRSMEYRDVDHRLPG

RBM6

401

P78332
DMERHRILFRYAGPE

TOP2B

651

Q02880
RMAAVEHRHSSGLPY

NPIPA5

216

E9PKD4
DMYHLSREGGAHERR

KIR3DS1

251

Q14943
LHARPSYHRLREDVM

RNF26

261

Q9BY78
QRDRHMSMHLGLRPY

ZBTB43

386

O43298
MGSYLAEHRRVHTGE

ZNF497

341

Q6ZNH5
ADLAMHRRVHTGDRP

ZNF668

321

Q96K58
SLDRHMLVHSGERPY

RREB1

111

Q92766
DLTRHMRSHTGERPY

RREB1

1526

Q92766
PGLVRYRHHERLCMG

TINF2

46

Q9BSI4
LMQHRRVHTGERPYE

ZNF211

356

Q13398
RHHEMPREYNEDEDP

IK

56

Q13123
FRMHERTHTGEKPYE

ZNF709

491

Q8N972
EALRLHRTGYADHMG

MYO18B

1251

Q8IUG5
RHRMQGDPDDTSHRG

ZNF598

171

Q86UK7
RRHERMHTGEKPYEC

ZNF563

241

Q8TA94
LTRHQRMHTGEEPYV

ZNF790

521

Q6PG37
CRRRHDEDVPDFLMH

TRPV3

146

Q8NET8
SIRRHRIMHSGDGPY

ZNF625

111

Q96I27
SLMDGHHYRRVARVD

WDR27

236

A2RRH5
RMGHHDDYYSRLRGR

ZRSR2

366

Q15696
DRHRAICRPMLAYRH

AVPR2

136

P30518
NHRRMHSGEIPYRCD

ZNF34

296

Q8IZ26
FQTHIRMHSGERPYE

ZNF439

341

Q8NDP4
CLMRHLYRRHPEVVG

ZBED4

496

O75132
MRDHERVHTGERPYH

ZNF784

211

Q8NCA9
MSRHHSRFERDYRVG

KLHL29

1

Q96CT2
ERMHTRRPYHVEDAE

MYO3B

326

Q8WXR4